Top News
Tumor Biopsy Does Not Improve Predictive Value of Trimodality Imaging
Estrogen Alone Appears to Lower Breast Cancer Risk and Death Long Term in Patient Subgroup
Residual Cancer Burden Is Prognostic Across Breast Cancer Subtypes in the Long-Term After Neoadjuvant Therapy
Detection of ctDNA Linked to Worse Clinical Outcomes in TNBC
Study Finds Many Breast Cancer Drugs Lack Substantial Clinical Benefit
Maintenance Durvalumab Shows Activity in Certain Breast Cancer Subgroups
Subcutaneous Pertuzumab and Trastuzumab Offers Convenience to Patients With HER2-Positive Breast Cancer
Adjuvant Paclitaxel and Trastuzumab Offer Same Survival Outcomes in HER2-Positive Early Breast Cancer
Pathologists in the Real World May Be Misinterpreting Immune-Cell Scores in Patients With Triple-Negative Breast Cancer
EDITORIAL ADVISORY BOARD
E. David Crawford, MD
Jeffrey M. Farma, MD
Featured
-
SABCS 2019 Coverage
News coverage from the 2019 San Antonio Breast Cancer Symposium. -
ASH 2019 Coverage
News coverage from the American Society of Hematology 2019 meeting in Orlando, FL. -
Triple-Negative Breast Cancer Now Has a Targeted Agent
Dr Hamilton discusses the approval of atezolizumab for first-line treatment of metastatic triple-negative breast cancer in combination with nab-paclitaxel chemotherapy. -
Why We Need to Change How We Look for Renal Cell Carcinoma Biomarkers
Proangiogenic or proimmunogenic genomic and transcriptomic signatures in the tumor microenvironment may have predictive value. -
When Patient-Reported Outcomes Could Pose Risks
During a recent conference on quality of life in patients with cancer, FDA-affiliated researchers debunked a notion about biases — but raised some concerns about PROs. -
How to Help Patients With Cancer Find Trustworthy Information Online
Patients may find misinformation on websites or social media forums, but doctors can help by recommending reliable sources. -
Prior Treatment Exposure May Contribute to Tumor Mutational Signature
Pretreatment significantly affected health outcomes for patients with metastatic breast cancer. -
Gender Bias in Oncology: Q&A With Dr Narjust Duma
Women are less likely to be introduced by their professional title and most likely to be introduced by first name. -
FDA Studies Assess Patient Reported Outcomes in Lung Cancer Trials
FDA analyses find trial-to-trial variation in the analysis of patient reported outcomes, underscoring the need for standardization.
More Features
Multinational Consensus Panel Confirms Benefits of Exercise, Updates Recommendations for Cancer Survivors
The American College of Sports Medicine reconvened the ACSM Roundtable to update its guidelines for prescribing exercise for patients and survivors of cancers.
Treatment Strategies for Lymphoma in Patients With HIV
Cancer, particularly non-Hodgkin lymphoma, remains a leading cause of death in patients with HIV who are being treated with antiretroviral therapy.
Brokering Early Palliative Care: How Nurses Approached a Misunderstood Topic
Palliative care can be effectively introduced along with other treatments, and the combination of care improves patient symptoms and quality of life.
Increased Risk for Mental Health Disorders Seen With Head and Neck Cancers
Mental health disorders may be an adverse effect of head and neck cancer diagnosis, treatment, or treatment morbidities.
FDA Label Restriction Triggers Increased Uptake of PD-L1 Assays in Urothelial Carcinoma
FDA label changes for certain immunotherapies may have prompted a marked increase in the use of PD-L1 assays.
